scholarly article | Q13442814 |
P356 | DOI | 10.4238/2012.JANUARY.13.1 |
P8608 | Fatcat ID | release_ttcovhfokvg37puvnpogulpguy |
P698 | PubMed publication ID | 22290468 |
P5875 | ResearchGate publication ID | 221791896 |
P2093 | author name string | J Huang | |
M Sun | |||
M Qin | |||
G-F Li | |||
C-X Yang | |||
G-S Li | |||
T-L Qian | |||
Y-Q Han | |||
P2860 | cites work | Differential effects of valproic acid on growth, proliferation and metastasis in HTB5 and HTB9 bladder cancer cell lines | Q39867753 |
P433 | issue | 1 | |
P304 | page(s) | 77-86 | |
P577 | publication date | 2012-01-13 | |
P1433 | published in | Genetics and Molecular Research | Q15762471 |
P1476 | title | Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression | |
P478 | volume | 11 |
Q60305702 | Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells |
Q35845089 | Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis |
Q36574546 | Butyrate histone deacetylase inhibitors. |
Q37039303 | Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action |
Q37114711 | Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail |
Q90398667 | Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties |
Q51599902 | N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells. |
Q28595847 | Sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care database |
Q26772803 | Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic Review |
Q53410584 | Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. |
Q36335796 | Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation |
Q36606222 | Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1. |
Search more.